Alan D Michelson Selected Research

thrombin receptor peptide SFLLRNP

12/2021	Sex-specific platelet activation through protease-activated receptor-1 in patients undergoing cardiac catheterization.
1/2021	Decreased platelet surface phosphatidylserine predicts increased bleeding in patients with severe factor VIII deficiency.
8/2015	Platelet function tests, independent of platelet count, are associated with bleeding severity in ITP.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alan D Michelson Research Topics

Disease

23	Thrombosis (Thrombus) 01/2022 - 08/2004
13	Acute Coronary Syndrome 12/2021 - 08/2004
12	Hemorrhage 01/2022 - 01/2006
10	Coronary Artery Disease (Coronary Atherosclerosis) 10/2017 - 01/2006
6	Myocardial Infarction 07/2018 - 11/2003
5	Sickle Cell Anemia (Hemoglobin S Disease) 01/2021 - 06/2008
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 11/2006
4	Ischemic Stroke 11/2021 - 01/2006
3	Venous Thromboembolism 12/2021 - 09/2004
3	Inflammation (Inflammations) 06/2021 - 07/2020
3	Thrombasthenia (Glanzmann Thrombasthenia) 01/2018 - 03/2003
3	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 09/2015 - 04/2012
2	Thromboembolism 12/2021 - 01/2006
2	Hemophilia A (Haemophilia) 01/2021 - 07/2020
2	Pain (Aches) 01/2021 - 10/2019
2	Infections 07/2020 - 10/2003
2	Neoplasms (Cancer) 07/2020 - 01/2013
2	Hypertension (High Blood Pressure) 01/2020 - 01/2015
2	Type 2 Diabetes Mellitus (MODY) 01/2020 - 04/2011
2	Diabetes Mellitus 01/2016 - 04/2011
2	Wiskott-Aldrich Syndrome 09/2015 - 07/2015
2	Ischemia 01/2014 - 10/2004
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2010 - 11/2009
2	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2006 - 09/2004
1	Sepsis (Septicemia) 01/2022
1	Chronic Disease (Chronic Diseases) 12/2021
1	Congenital Heart Defects (Congenital Heart Defect) 12/2021
1	Epistaxis (Nosebleed) 11/2021
1	Venous Thrombosis (Deep-Vein Thrombosis) 11/2021
1	Pulmonary Embolism 11/2021
1	Body Weight (Weight, Body) 11/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Hemarthrosis 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 10/2020
1	Splenomegaly 10/2020
1	Fibrosis (Cirrhosis) 10/2020
1	Thrombotic Microangiopathies 07/2020
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020
1	Cognitive Dysfunction 01/2020
1	Acute Chest Syndrome 10/2019
1	Stroke (Strokes) 07/2018

Drug/Important Bio-Agent (IBA)

15	Clopidogrel (Plavix)FDA Link 01/2016 - 01/2006
13	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2021 - 09/2004
11	Adenosine Diphosphate (ADP)IBA 01/2021 - 11/2003
7	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2020 - 01/2006
5	Glycoproteins (Glycoprotein)IBA 01/2020 - 11/2003
5	Prasugrel Hydrochloride FDA Link 04/2011 - 01/2006
3	IntegrinsIBA 01/2022 - 07/2015
3	P-SelectinIBA 01/2022 - 08/2015
3	AnticoagulantsIBA 12/2021 - 06/2008
3	thrombin receptor peptide SFLLRNPIBA 12/2021 - 08/2015
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2017
3	Inosine Triphosphate (ITP)IBA 09/2015 - 04/2012
2	Membrane Glycoproteins (Membrane Glycoprotein)IBA 06/2021 - 01/2018
2	Hemostatics (Antihemorrhagics)IBA 07/2020 - 03/2008
2	Purinergic P2Y Receptor AntagonistsIBA 01/2020 - 01/2018
2	Thrombin Receptors (Thrombin Receptor)IBA 01/2020 - 08/2015
2	TicagrelorIBA 10/2019 - 01/2006
2	MetalsIBA 01/2018 - 01/2006
2	Cytochrome P-450 CYP2C19IBA 01/2016 - 11/2011
2	eltrombopag FDA Link 09/2015 - 04/2012
2	Platelet Membrane Glycoprotein IIbIBA 08/2015 - 03/2008
2	Adenosine (Adenocard)FDA LinkGeneric 01/2014 - 01/2008
2	Abciximab (ReoPro)FDA Link 05/2013 - 11/2003
2	CD40 Ligand (CD40L)IBA 01/2010 - 08/2004
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 09/2009 - 03/2008
2	Heparin (Liquaemin)FDA LinkGeneric 06/2008 - 09/2004
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 06/2008 - 09/2004
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Warfarin (Coumadin)FDA LinkGeneric 12/2021
1	RivaroxabanIBA 11/2021
1	omega-Chloroacetophenone (Mace)IBA 04/2021
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 04/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	Factor VIII (Coagulation Factor VIII)IBA 01/2021
1	PhosphatidylserinesIBA 01/2021
1	Thrombin FDA Link 01/2021
1	Annexin A5IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 10/2020
1	AutoantibodiesIBA 10/2020
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 10/2020
1	von Willebrand FactorIBA 07/2020
1	Factor V (Coagulation Factor V)IBA 07/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Soluble Guanylyl CyclaseIBA 01/2020
1	vorapaxarIBA 01/2020
1	praliciguatIBA 01/2020
1	Analgesics (Analgesic Drugs)IBA 10/2019
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2019
1	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2019
1	6- (4- methyl- 1- (pyrimidin- 2- ylmethyl)pyrrolidin- 3- yl)- 1- (tetrahydro- 2H- pyran- 4- yl)- 1,5- dihydro- 4H- pyrazolo(3,4- d)pyrimidin- 4- oneIBA 01/2019
1	platelet membrane glycoprotein VIIBA 01/2018
1	AntibodiesIBA 01/2018

Therapy/Procedure

22	Therapeutics 12/2021 - 09/2004
9	Percutaneous Coronary Intervention 04/2021 - 11/2003
6	Stents 06/2016 - 03/2008
2	Drug-Eluting Stents 03/2008 - 01/2006
1	Fontan Procedure (Fontan Operation) 01/2022
1	Operative Surgical Procedures 12/2021
1	Drug Therapy (Chemotherapy) 01/2020